CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder

Cancer Investigation

Volumn 31, Issue 2, 2013, Pages 132-139

  Yang, Zhu Lin ^a   Miao, Xiongying ^a   Xiong, Li ^a   Zou, Qiong ^b   Yuan, Yuan ^b   Li, Jinghe ^c   Liang, Lufeng ^d   Chen, Meigui ^e   Chen, Senlin ^f  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c School of Basic Medical Science   (China)

^d Hunan Provincial People's Hospital   (China)

^e Loudi Central Hospital   (China)

^f HUNAN CANCER HOSPITAL   (China)

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; Arp3; CFL1; Gallbladder cancer; Metastasis; Prognosis; Squamous cell carcinoma

Indexed keywords

ACTIN RELATED PROTEIN 3; COFILIN 1;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ACTIN-RELATED PROTEIN 3; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; COFILIN 1; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873166868     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.756113     Document Type: Article

References (32)

1. Liu DC, Yang ZL. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagn Cytopathol 2011, doi: 10.1002/dc.21821.
2. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nature Rev Cancer 2009;9:274-284.
3. Wang W, Eddy R,Condeelis J.The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007;7:429-440. (Pubitemid 46809168)
4. Bamburg JR,Wiggan OP. ADF/cofilin and actin dynamics in disease. Trends Cell Biol 2002;12:598-605.
5. Vartiainen MK, Machesky LM. The WASP-Arp2/3 pathway: genetic insights. Curr Opin Cell Biol 2004;16:174-181. (Pubitemid 38757294)
6. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, Ampe C. Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol 2008;87:649-667.
7. M?uller CB, de Barros RL, Castro MA, Lopes FM, Meurer RT, Roehe A, Mazzini G, Ulbrich-Kulczynski JM, Dal-Pizzol F, FernandesMC, Moreira JC, Xavier LL, Klamt F. Validation of cofilin- 1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort. J Cancer Res Clin Oncol 2011;137:1309-1316.
8. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, Arenberg DA, Reddy RC, Akulapalli S,Thannickal VJ, Standiford TJ, Andrews PC, Omenn GS. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/ invasive phenotype. J Proteome Res 2006;5:1143-1154. (Pubitemid 43727792)
9. Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, Eardley I, Selby PJ, Banks RE. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003;3:1620-1632. (Pubitemid 37048086)
10. Martoglio AM, Tom BD, Starkey M, Corps AN, Charnock- Jones DS, Smith SK. Changes in tumorigenesis and angiogenesisrelated gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol Med 2000;6: 750-765.
11. Turhani D, Krapfenbauer K,Thurnher D, Langen H, Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 2006;27:1417-1423.
12. Sinha P, H?utter G, K?ottgen E, Dietel M, Schadendorf D, Lage H. Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-signa (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. ElectroPhoresis 1999;20:2952-2960. (Pubitemid 29517227)
13. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004;64:8585-8594. (Pubitemid 39552071)
14. Wang W, Eddy R,Condeelis J.The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007;7:429-440. (Pubitemid 46809168)
15. CastroMA, Dal-Pizzol F, Zdanov S, Soares M, M?uller CB, Lopes FM, Zanotto-Filho A, da Cruz Fernandes M, Moreira JC, Shacter E, Klamt F. CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer. Cancer 2010;116:3645-3655.
16. N?urnberg A, Kitzing T, Grosse R. Nucleating actin for invasion. Nat Rev Cancer 2011;11:177-187.
17. Yokotsuka M, Iwaya K, Saito T, Pandiella A, Tsuboi R, Kohno N, Matsubara O, Mukai K. Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer. Breast Cancer Res Treat 2011;126:311-318.
18. Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, H?uttelmaier S, Zavadil J, Cermak L, Bottinger EP, Singer RH, White JG, Segall JE, Condeelis JS. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002;62: 6278-6288. (Pubitemid 35244482)
19. Otsubo T, Iwaya K,Mukai Y,Mizokami Y, Serizawa H,Matsuoka T,Mukai K. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol 2004;17:461-467. (Pubitemid 41646602)
20. Semba S, Iwaya K,Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verprolinehomologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res 2006;12:2449-2454.
21. Zheng HC, Zheng YS, Li XH, Takahashi H, Hara T, Masuda S, Yang XH, Guan YF, Takano Y. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Anticancer Res 2008;28:2225-2232.
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
23. Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am 2010;39:331-342.
24. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 2007;11:671-681.
25. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 2004;11:310-315. (Pubitemid 40486772)
26. Ootani T, Shirai Y, Tsukada K,Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 1992;69:2647-2652.
27. Roa JC,Tapia O, CakirA, BasturkO, DursunN, AkdemirD, Saka B, Losada H, Bagci P, Adsay NV. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol 2011;24:1069-1078.
28. Park SB, Kim YH, Rho HL, Chae GB, Hong SK. Primary carcinosarcoma of the gallbladder. J Korean Surg Soc 2012;82:54-58.
29. Liu DC, Yang ZL. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract 2011;207:472-478.
30. Nishihara K, Nagai E, Izumi Y, Yamaguchi K, Tsuneyoshi M. Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases. Jpn J Cancer Res 1994;85:389-399. (Pubitemid 24129620)
31. Kondo M, Dono K, SakonM, Shimizu J, Nagano H, Nakamori S, Umeshita K, Wakasa K, Monden M. Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology 2002;49:1230-1234.
32. van Rheenen J, Song X, van Roosmalen W, Cammer M, Chen X, Desmarais V, Yip SC, Backer JM, Eddy RJ, Condeelis JS. EGFinduced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol 2007;179:1247-1259. (Pubitemid 350277742)